PEAK vs PTGX
PEAK (PEAK) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
PEAK (PEAK) common stock.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
PEAK does not have a complete income-statement cache yet.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
PTGX currently screens at market cap $7.25B.
Not investment advice. Open the PEAK and PTGX stock pages for the full models.
Not investment advice.